Bristol-Myers Squibb Co (MEX:BMY) Institutional Ownership : 55.14% (As of Apr. 03, 2025)

View and export this data going back to 2004. Start your Free Trial

What is Bristol-Myers Squibb Co Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bristol-Myers Squibb Co's institutional ownership is 55.14%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bristol-Myers Squibb Co's Float Percentage Of Total Shares Outstanding is 99.66%.

Bristol-Myers Squibb Co Institutional Ownership Historical Data

The historical data trend for Bristol-Myers Squibb Co's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Institutional Ownership Chart

Bristol-Myers Squibb Co Historical Data

The historical data trend for Bristol-Myers Squibb Co can be seen below:

	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30	2024-12-31	2025-01-31	2025-02-28
Institutional Ownership	52.52	51.51	52.74	53.64	53.61	54.59	54.96	54.97	55.15	55.14

Bristol-Myers Squibb Co Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Bristol-Myers Squibb Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (MEX:BMY) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

BMYMP.PFD:USA BMY:USA BMY:Peru 1BMY:Italy BRMd:UK 0R1F:UK BRM:Germany BRM:Germany BRM:Germany BRM:Germany BMYB34:Brazil BMYS:Austria BMY:Argentina

Address

Route 206 and Province Line Road, Princeton, New Jersey, NJ, USA, 08543

Website

https://www.bms.com

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.